Share

Live Web cast: 'Toward a Future Without Cancer: Goals for the 21st Century'

Symposium features leaders of NCI, FDA, ACS, BIO and the CEO Roundtable on Cancer

WHAT: Live Webcast - “Toward a Future Without Cancer: Goals for the 21st Century”

Hosted by Fox Chase Cancer Center, this symposium brings together top leaders from government, industry, advocacy and academia followed by a panel discussion with all participants.

WHO: Michael V. Seiden, M.D., Ph.D., President/CEO, Fox Chase Cancer Center
John E. Niederhuber, M.D., Director, National Cancer
Andrew C. von Eschenbach, M.D., Commissioner, U.S. Food and Drug Administration
Ed Harlow, Ph.D., Harvard Medical School
Robert A. Ingram, Founder, CEO Roundtable on Cancer
John R. Seffrin, Ph.D., CEO, American Cancer Society
The Honorable James C. Greenwood, President/CEO, Biotechnology Industry Organization
Panel moderator: Clifford Goodman, Ph.D., Sr. V.P., The Lewin Group

WHEN: Thursday, June 21, 2007; 1:30p.m. ET (the panel discussion begins at approximately 4:15pm ET)

WHERE: www.fccc.edu/symposium (windows users need Apple QuickTime to view they symposium http://www.apple.com/quicktime/download/win.html)

NOTE: A complete schedule of symposium activities can be found at www.fccc.edu/symposium.

Fox Chase Cancer Center was founded in 1904 in Philadelphia as the nation's first cancer hospital. In 1974, Fox Chase became one of the first institutions designated as a National Cancer Institute Comprehensive Cancer Center. Fox Chase conducts basic, clinical, population and translational research; programs of prevention, detection and treatment of cancer; and community outreach. For more information about Fox Chase activities, visit the Center’s web site at www.fccc.edu or call 1-888-FOX CHASE.

Share

AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert! system.